JP2018520644A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018520644A5 JP2018520644A5 JP2017557212A JP2017557212A JP2018520644A5 JP 2018520644 A5 JP2018520644 A5 JP 2018520644A5 JP 2017557212 A JP2017557212 A JP 2017557212A JP 2017557212 A JP2017557212 A JP 2017557212A JP 2018520644 A5 JP2018520644 A5 JP 2018520644A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- cell
- cancer
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021059554A JP7513561B2 (ja) | 2015-05-06 | 2021-03-31 | 結腸直腸がん（ｃｒｃ）およびその他のがんに対する免疫療法で使用するための新規ペプチドおよびペプチドとそのスキャフォールドとの組み合わせ |
| JP2024102557A JP2024125363A (ja) | 2015-05-06 | 2024-06-26 | 結腸直腸がん（ｃｒｃ）およびその他のがんに対する免疫療法で使用するための新規ペプチドおよびペプチドとそのスキャフォールドとの組み合わせ |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562157684P | 2015-05-06 | 2015-05-06 | |
| GB1507719.1 | 2015-05-06 | ||
| US62/157,684 | 2015-05-06 | ||
| GBGB1507719.1A GB201507719D0 (en) | 2015-05-06 | 2015-05-06 | Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers |
| PCT/EP2016/060007 WO2016177784A1 (en) | 2015-05-06 | 2016-05-04 | Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021059554A Division JP7513561B2 (ja) | 2015-05-06 | 2021-03-31 | 結腸直腸がん（ｃｒｃ）およびその他のがんに対する免疫療法で使用するための新規ペプチドおよびペプチドとそのスキャフォールドとの組み合わせ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018520644A JP2018520644A (ja) | 2018-08-02 |
| JP2018520644A5 true JP2018520644A5 (enExample) | 2019-04-18 |
| JP6985153B2 JP6985153B2 (ja) | 2021-12-22 |
Family
ID=56026813
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017557212A Expired - Fee Related JP6985153B2 (ja) | 2015-05-06 | 2016-05-04 | 結腸直腸がん（ｃｒｃ）およびその他のがんに対する免疫療法で使用するための新規ペプチドおよびペプチドとそのスキャフォールドとの組み合わせ |
| JP2024102557A Withdrawn JP2024125363A (ja) | 2015-05-06 | 2024-06-26 | 結腸直腸がん（ｃｒｃ）およびその他のがんに対する免疫療法で使用するための新規ペプチドおよびペプチドとそのスキャフォールドとの組み合わせ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024102557A Withdrawn JP2024125363A (ja) | 2015-05-06 | 2024-06-26 | 結腸直腸がん（ｃｒｃ）およびその他のがんに対する免疫療法で使用するための新規ペプチドおよびペプチドとそのスキャフォールドとの組み合わせ |
Country Status (14)
| Country | Link |
|---|---|
| US (7) | US12150979B2 (enExample) |
| JP (2) | JP6985153B2 (enExample) |
| KR (1) | KR20240161207A (enExample) |
| CN (1) | CN107810193B (enExample) |
| CL (1) | CL2017002766A1 (enExample) |
| CO (1) | CO2017010830A2 (enExample) |
| CR (1) | CR20230131A (enExample) |
| CY (1) | CY1124038T1 (enExample) |
| HR (1) | HRP20210528T1 (enExample) |
| IL (2) | IL308202A (enExample) |
| MX (1) | MX2022002263A (enExample) |
| MY (1) | MY185616A (enExample) |
| PH (2) | PH12021550910A1 (enExample) |
| TW (2) | TWI800770B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20230131A (es) | 2015-05-06 | 2023-06-23 | Immatics Biotechnologies Gmbh | NUEVOS PÉPTIDOS Y NUEVAS COMBINACIONES DE PÉPTIDOS Y DE SOPORTES PARA LA INMUNOTERAPIA CONTRA EL CARCINOMA COLORRECTAL Y OTROS TIPOS DE CÁNCER (Divisional Exp. 2017-0497) |
| PH12022551111A1 (en) | 2015-10-05 | 2023-08-23 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| GB201603987D0 (en) | 2016-03-08 | 2016-04-20 | Immatics Biotechnologies Gmbh | Uterine cancer treatments |
| GB201604490D0 (en) * | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Peptides combination of peptides for use in immunotherapy against cancers |
| CN112816682B (zh) * | 2021-01-28 | 2024-03-26 | 浙江省农业科学院 | 三螺旋dna分子开关探针及其在ota比色快速检测中的应用 |
| JP7766904B2 (ja) * | 2021-06-04 | 2025-11-11 | 地方独立行政法人東京都健康長寿医療センター | 前立腺がん治療用医薬組成物 |
| CN117406799B (zh) * | 2023-10-24 | 2026-07-21 | 青岛大学 | 多容液位系统的液位跟踪控制方法、系统、设备以及介质 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2677653A1 (fr) | 1991-06-17 | 1992-12-18 | Inst Nat Sante Rech Med | Fragments peptidiques issus du cytochrome humain p450 iid6, anticorps anti-fragments peptidiques et leurs applications dans le diagnostic de l'hepatite auto-immune. |
| US5891857A (en) | 1996-02-20 | 1999-04-06 | Vanderbilt University | Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins |
| US6773878B1 (en) | 1999-11-09 | 2004-08-10 | Eos Biotechnology, Inc. | Methods of diagnosing of colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| EP1290217A2 (en) | 2000-02-04 | 2003-03-12 | Aeomica, Inc. | Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| SE0203137D0 (sv) | 2002-10-24 | 2002-10-24 | Karolinska Innovations Ab | Drug target in cancer therapy |
| WO2004108964A1 (en) | 2003-06-04 | 2004-12-16 | Agency For Science, Technology And Research | Differentially regulated hepatocellular carcinoma genes and uses thereof |
| JP2006166789A (ja) * | 2004-12-15 | 2006-06-29 | Hiroshima Univ | 癌の新規診断方法 |
| CN101168566A (zh) * | 2006-10-26 | 2008-04-30 | 北京市肿瘤防治研究所 | 抗肿瘤特异性标志蛋白ts/medp的抗体制备及用途 |
| HUE025636T2 (en) * | 2007-07-27 | 2016-04-28 | Immatics Biotechnologies Gmbh | Novel immunogenic epitopes for immunotherapy |
| US8492347B2 (en) * | 2007-10-17 | 2013-07-23 | The Regents Of The University Of California | Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus |
| ES2536465T3 (es) * | 2008-10-01 | 2015-05-25 | Immatics Biotechnologies Gmbh | Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres |
| EP2771349B1 (en) | 2011-09-16 | 2020-02-26 | Iogenetics, LLC. | Bioinformatic processes for determination of peptide binding |
| WO2014127296A1 (en) * | 2013-02-14 | 2014-08-21 | Immunocellular Therapeutics, Ltd | Cancer vaccines and vaccination methods |
| TWI714869B (zh) | 2013-08-05 | 2021-01-01 | 德商伊瑪提克斯生物科技有限公司 | 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物 |
| GB201319446D0 (en) | 2013-11-04 | 2013-12-18 | Immatics Biotechnologies Gmbh | Personalized immunotherapy against several neuronal and brain tumors |
| GB201505305D0 (en) | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| CR20230131A (es) | 2015-05-06 | 2023-06-23 | Immatics Biotechnologies Gmbh | NUEVOS PÉPTIDOS Y NUEVAS COMBINACIONES DE PÉPTIDOS Y DE SOPORTES PARA LA INMUNOTERAPIA CONTRA EL CARCINOMA COLORRECTAL Y OTROS TIPOS DE CÁNCER (Divisional Exp. 2017-0497) |
| CL2022002183A1 (es) | 2022-08-11 | 2023-02-24 | Immatics Biotechnologies Gmbh | Péptidos, combinaciones y soportes para inmunoterapia contra carcinoma colorrectal y otros tipos de cáncer |
| CL2022002182A1 (es) | 2022-08-11 | 2023-02-24 | Immatics Biotechnologies Gmbh | Péptidos, combinaciones y soportes para inmunoterapia contra carcinoma colorrectal y otros tipos de cáncer |
-
2016
- 2016-05-04 CR CR20230131A patent/CR20230131A/es unknown
- 2016-05-04 MY MYPI2017704127A patent/MY185616A/en unknown
- 2016-05-04 CN CN201680025708.XA patent/CN107810193B/zh not_active Expired - Fee Related
- 2016-05-04 IL IL308202A patent/IL308202A/en unknown
- 2016-05-04 JP JP2017557212A patent/JP6985153B2/ja not_active Expired - Fee Related
- 2016-05-04 HR HRP20210528TT patent/HRP20210528T1/hr unknown
- 2016-05-04 KR KR1020247036001A patent/KR20240161207A/ko active Pending
- 2016-05-04 PH PH1/2021/550910A patent/PH12021550910A1/en unknown
- 2016-05-06 TW TW109141683A patent/TWI800770B/zh not_active IP Right Cessation
- 2016-05-06 TW TW112111135A patent/TW202330590A/zh unknown
-
2017
- 2017-10-18 IL IL255126A patent/IL255126A0/en unknown
- 2017-10-25 CO CONC2017/0010830A patent/CO2017010830A2/es unknown
- 2017-10-31 MX MX2022002263A patent/MX2022002263A/es unknown
- 2017-11-02 CL CL2017002766A patent/CL2017002766A1/es unknown
- 2017-11-02 PH PH12017501994A patent/PH12017501994A1/en unknown
-
2021
- 2021-04-15 CY CY20211100329T patent/CY1124038T1/el unknown
- 2021-06-11 US US17/345,457 patent/US12150979B2/en active Active
-
2022
- 2022-11-18 US US18/056,858 patent/US20230088845A1/en not_active Abandoned
- 2022-11-18 US US18/056,887 patent/US20230086855A1/en not_active Abandoned
- 2022-12-08 US US18/063,396 patent/US20230203113A1/en not_active Abandoned
- 2022-12-08 US US18/063,418 patent/US20230212244A1/en not_active Abandoned
- 2022-12-08 US US18/063,430 patent/US20230203114A1/en not_active Abandoned
-
2024
- 2024-06-26 JP JP2024102557A patent/JP2024125363A/ja not_active Withdrawn
-
2025
- 2025-11-10 US US19/384,513 patent/US20260116950A1/en active Pending